Press Center

On 24 August 2026, Decree of the President of the Russian Federation No. 604 “On Measures to Ensure the Security of Critical Infrastructure Facilities of the Russian Federation” (the Decree) was published and entered into force. The Decree empowers the Government of the Russian Federation, acting upon an instruction of the President, to introduce temporary administration over business entities connected with critical infrastructure facilities.

Lidings' lawyers have prepared a review following the Roskomnadzor "Open Day" held on 14 August 2026, and have compiled the regulator's responses to practical questions from personal data operators. Below are the key findings from the event.

We invite you to a webinar on antitrust risks for pharmaceutical companies when setting prices for medicinal products.

On May 26, Moscow will host the XVII Antitrust Forum — the flagship event in Russian competition law. The forum is traditionally held with the support of the Federal Antimonopoly Service of Russia (FAS Russia) and the Association of Antimonopoly Experts (AAE). This year’s main theme is competition in the digital economy.

Lidings is an official partner of the forum and is organising a special session: “Pharmaceuticals & Antitrust: The Fight for Fair Competition Amid Economic Challenges.”

April 9^th,2026 annual conference Pharmaceuticals – 2026: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss how the market has changed in 2025 and what awaits us in 2026.

India has long and firmly established itself as the ‘pharmacy of the world’, as the country produces a fifth of all generics and provides affordable medicines to millions of people across the globe. However, India is now transitioning from copying innovative molecules to creating them. Amid the restructuring of global supply chains and strategic rapprochement with Russia, India is becoming both a battleground for fierce patent wars and a unique laboratory for joint research. How can Russian pharmaceutical companies establish intellectual property protection in a jurisdiction where the balance between the interests of pharmaceutical giants and the affordability of medicines for the population is enshrined in law? Boris Malakhov and Natalya Thotahewage analyse the key features of patenting and the prospects for technological alliances between Moscow and Delhi.

On February 17, 2026, the annual flagship seminar of Lidings, "Predictions 2026: Crystal Clarity Instead of Legal Fog," was held at the Hotel Metropol.

The event marked the beginning of a series of celebrations dedicated to the firm's 20th anniversary and brought together over 70 representatives from 50 Russian and international companies.

Lidings' lawyers together with invited speakers from the corporate sector discussed key legislative changes and shared current trends and practical tools.

2026 is a special year for our team — it marks our 20th anniversary. And we are especially pleased to kick it off with a seminar where we will look into the "Crystal of Predictions": back to the past — to review the key legal developments of the past year, and forward to the future — to share crystal-clear insights on the key business trends awaiting in 2026.